person

Juan Á. C. R.

Country
Spain
Department
Neurology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
3
Sites with multiple studies

Has run more than one trial at 3 of 14 partner sites.

Specializations

Stroke and cerebrovascular disease

Clinical activity includes acute ischemic stroke, high-risk transient ischemic attack, intracerebral haemorrhage, and stroke prevention, with interest in reperfusion strategies, antithrombotic approaches, and acute neurovascular care.

  • Acute ischemic stroke
  • Transient ischemic attack
  • Intracerebral haemorrhage
  • Thrombolysis

This area also extends to mechanical thrombectomy, secondary prevention, and treatment strategies for vascular neurologic emergencies.

Demyelinating and autoimmune neurological disorders

Research involvement covers multiple sclerosis and related inflammatory neurologic conditions, with therapeutic interest in immune modulation and long-term disease control.

  • Multiple sclerosis
  • Relapsing forms of MS
  • Nervous system diseases

The portfolio reflects attention to therapies targeting immune activity in chronic neurologic disease.

Cardiovascular and thrombotic disorders

Clinical interests include heart failure, spontaneous coronary artery dissection, hypertension, cardiomyopathy, and venous thrombosis, alongside broader cardiovascular risk reduction.

  • Heart failure
  • Spontaneous coronary artery dissection
  • Cardiomyopathy
  • Deep vein thrombosis

Therapeutic activity also includes prevention of ischemic events and management of high-risk vascular disease.

Gastroenterology and inflammatory bowel disease

Research spans Crohn's disease and ulcerative colitis, with additional interest in acute digestive conditions such as acute pancreatitis and chronic liver disease.

  • Crohn's disease
  • Ulcerative colitis
  • Acute pancreatitis
  • Chronic liver disease

The therapeutic focus includes immune-mediated intestinal disease and supportive treatment in hepatopancreatic disorders.

Metabolic, endocrine, and renal disease

Clinical trial involvement also covers type 1 diabetes, obesity, polycystic ovary syndrome, chronic kidney disease, IgA nephropathy, and end-stage kidney disease.

  • Type 1 diabetes
  • Chronic kidney disease
  • IgA nephropathy
  • End-stage kidney disease

These areas reflect interest in metabolic regulation, immune-mediated renal injury, and kidney-supportive therapies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.